258 related articles for article (PubMed ID: 16200457)
21. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
[TBL] [Abstract][Full Text] [Related]
22. Leucocyte-specific protein (LSP1) in malignant lymphoma and Hodgkin's disease.
Marafioti T; Jabri L; Pulford K; Brousset P; Mason DY; Delsol G
Br J Haematol; 2003 Feb; 120(4):671-8. PubMed ID: 12588355
[TBL] [Abstract][Full Text] [Related]
23. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
24. [Classical Hodgkin's lymphoma: biology and grey zones].
Gaulard P; Brousse N
Ann Pathol; 2004 Sep; 24(4):330-48. PubMed ID: 15567950
[TBL] [Abstract][Full Text] [Related]
25. Frequent expression of FAS/APO-1 in Hodgkin's disease and anaplastic large cell lymphomas.
Xerri L; Carbuccia N; Parc P; Hassoun J; Birg F
Histopathology; 1995 Sep; 27(3):235-41. PubMed ID: 8522287
[TBL] [Abstract][Full Text] [Related]
26. The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma.
Schneider EM; Torlakovic E; Stühler A; Diehl V; Tesch H; Giebel B
J Pathol; 2004 Dec; 204(5):538-45. PubMed ID: 15538755
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
28. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease.
Foss HD; Araujo I; Demel G; Klotzbach H; Hummel M; Stein H
J Pathol; 1997 Sep; 183(1):44-50. PubMed ID: 9370946
[TBL] [Abstract][Full Text] [Related]
29. CD30 expression in follicular lymphoma.
Piris M; Gatter KC; Mason DY
Histopathology; 1991 Jan; 18(1):25-9. PubMed ID: 1849500
[TBL] [Abstract][Full Text] [Related]
30. CD20 positivity in classical Hodgkin's lymphoma: Diagnostic challenge or targeting opportunity.
Barakzai MA; Pervez S
Indian J Pathol Microbiol; 2009; 52(1):6-9. PubMed ID: 19136769
[TBL] [Abstract][Full Text] [Related]
31. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma.
Bräuninger A; Hansmann ML; Strickler JG; Dummer R; Burg G; Rajewsky K; Küppers R
N Engl J Med; 1999 Apr; 340(16):1239-47. PubMed ID: 10210707
[TBL] [Abstract][Full Text] [Related]
32. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
Schmidt U; Herbst J; Metz KA; Leder LD
J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
[TBL] [Abstract][Full Text] [Related]
33. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
Kamel OW; Gelb AB; Shibuya RB; Warnke RA
Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
[TBL] [Abstract][Full Text] [Related]
34. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
[TBL] [Abstract][Full Text] [Related]
35. The leukocyte semaphorin CD100 is expressed in most T-cell, but few B-cell, non-Hodgkin's lymphomas.
Dorfman DM; Shahsafaei A; Nadler LM; Freeman GJ
Am J Pathol; 1998 Jul; 153(1):255-62. PubMed ID: 9665486
[TBL] [Abstract][Full Text] [Related]
36. Expression of vimentin and epithelial membrane antigen in human malignant lymphomas.
Sarker AB; Akagi T; Yoshino T; Hoshida Y; Takahashi K; Horie Y
Acta Pathol Jpn; 1990 Aug; 40(8):581-7. PubMed ID: 2239313
[TBL] [Abstract][Full Text] [Related]
37. MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
Borovecki A; Korac P; Ventura RA; Perisa MM; Banham AH; Dominis M
Pathol Int; 2007 Jan; 57(1):47-51. PubMed ID: 17199743
[TBL] [Abstract][Full Text] [Related]
38. Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas.
Tedoldi S; Paterson JC; Cordell J; Tan SY; Jones M; Manek S; Dei Tos AP; Roberton H; Masir N; Natkunam Y; Pileri SA; Facchetti F; Hansmann ML; Mason DY; Marafioti T
J Pathol; 2006 Aug; 209(4):454-63. PubMed ID: 16739114
[TBL] [Abstract][Full Text] [Related]
39. Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry.
Rüdiger T; Ott G; Ott MM; Müller-Deubert SM; Müller-Hermelink HK
Am J Surg Pathol; 1998 Oct; 22(10):1184-91. PubMed ID: 9777980
[TBL] [Abstract][Full Text] [Related]
40. Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas.
Sáez AI; Artiga MJ; Sánchez-Beato M; Sánchez-Verde L; García JF; Camacho FI; Franco R; Piris MA
Mod Pathol; 2002 Mar; 15(3):211-20. PubMed ID: 11904338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]